BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6827310)

  • 1. Myasthenic patients' IgG causes redistribution of acetylcholine receptors: freeze-fracture studies.
    Pumplin DW; Drachman DB
    J Neurosci; 1983 Mar; 3(3):576-84. PubMed ID: 6827310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
    Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
    N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
    Kuncl RW; Drachman DB; Adams R; Lehar M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):582-9. PubMed ID: 8246131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine receptors and myasthenia.
    Lindstrom JM
    Muscle Nerve; 2000 Apr; 23(4):453-77. PubMed ID: 10716755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of acetylcholine receptor loss in myasthenia gravis.
    Drachman DB; Adams RN; Stanley EF; Pestronk A
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):601-10. PubMed ID: 6249894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera.
    Sophianos D; Tzartos SJ
    J Autoimmun; 1989 Dec; 2(6):777-89. PubMed ID: 2619869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
    Ashizawa T; Elias SB; Appel SH
    Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption and reformation of the acetylcholine receptor clusters of cultured rat myotubes occur in two distinct stages.
    Pumplin DW; Bloch RJ
    J Cell Biol; 1987 Jan; 104(1):97-108. PubMed ID: 3793764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules.
    Sterz R; Hohlfeld R; Rajki K; Kaul M; Heininger K; Peper K; Toyka KV
    Muscle Nerve; 1986 May; 9(4):306-12. PubMed ID: 2423869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
    Drachman DB; Angus CW; Adams RN; Kao I
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
    Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins.
    Ashizawa T; Appel SH
    Neurology; 1985 Dec; 35(12):1748-53. PubMed ID: 4069366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immunity in myasthenia gravis: clinical correlations of anti-receptor antibody avidity and titer.
    Tindall RS
    Ann N Y Acad Sci; 1981; 377():316-31. PubMed ID: 6803647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a myasthenic serum on the acetylcholine receptors of C2 myotubes. II. Functional inactivation of the receptor.
    Maricq AV; Gu Y; Hestrin S; Hall Z
    J Neurosci; 1985 Jul; 5(7):1917-24. PubMed ID: 2410577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogold surface replica study on the distribution of acetylcholine receptors in cultured rat myotubes.
    Veltel D; Robenek H
    J Histochem Cytochem; 1988 Oct; 36(10):1295-303. PubMed ID: 3418108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-induced degradation of acetylcholine receptor in myasthenia gravis: clinical correlates and pathogenetic significance.
    Tronconi BC; Brigonzi A; Fumagalli G; Sher M; Cosi V; Piccolo G; Clementi F
    Neurology; 1981 Nov; 31(11):1440-4. PubMed ID: 7198191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.